Studies from Laboratory of Molecular Biology Provide New Data on Cancer Research (BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale)

Source :: Obesity, Fitness & Wellness Week. October 5, 2019, 6035
Publication Year :: 2019
Abstract: 2019 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Cancer Research. According to news [...]

Subjects :: United States. Food and Drug Administration
Clinical trials
Molecular biology
Physical fitness
Dabrafenib
Cancer -- Genetic aspects -- Drug therapy
Cancer research
Gene mutation
Trametinib
Cancer patients -- Drug therapy
Drug approval
Non-small cell lung cancer -- Genetic aspects -- Drug therapy
Obesity
Editors
Lung cancer
Health
Laboratory of Molecular Biology

Tools